Because we don't produce raw materials and don't have any investment for lab oriented drug synthesis due to the absence of qualitatve raw material industry in our country, then we don't have any clear data about product stability of bangladeshi remidesvir but the one gileads has liscenced to ferozson is qualitatively proven and will be supplied to 127 countries that will be the great boost for Pharmceutical exports of Pakistan, what searle is trying to do is to capture the local market before ferozsons by just importing a finish product and just selling it to local market.
Its the drug favipiravir of fujifilm, japan ... The avifavir is just a commercial name. But the issue is that japanese pharmaceuticals are not firmly linked with pakistani pharmaceutical market and also their drug price are not feasible with our markets so it will take time to get hands on favipiravir otherwise the same bangladeshi pharmaceutical that is licked with remidasvir has also claimed to have produced favipiravir.
